July 24, 2012 — Mevion Medical Systems announced today that it has delivered the superconducting synchrocyclotron for the Mevion S250 Proton Therapy System currently under installation at Robert Wood Johnson University Hospital in New Brunswick, N.J., the flagship cancer hospital of The Cancer Institute of New Jersey and the principle teaching hospital of UMDNJ-Robert Wood Johnson Medical School. This is the second Mevion S250 proton therapy system was delivered in the past six months, both installed at NCI-designated Comprehensive Cancer Centers.

Powered by a TriNiobium Core, the Mevion S250 is a modern and first-of-its-kind proton therapy system that provides the same precise, non-invasive treatment capabilities and advantages of complex, large and costly proton therapy systems but with a significantly reduced footprint, improved reliability, more advanced clinical systems, and lower implementation and operational costs. 

The Mevion S250 has recently received United States Food and Drug Administration (FDA) 510(k) clearance and CE mark enabling Mevion customers to treat patients. 

For more information: www.mevion.com

 


Related Content

News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
News | Ultrasound Imaging

September 8, 2023 — When diagnosing and treating cancer patients, the dynamics of blood flow to and from a suspected ...

Time September 08, 2023
arrow
News | ASTRO

September 7, 2023 — American Society for Radiation Oncology (ASTRO) President Jeff Michalski, MD, MBA, FASTRO, will join ...

Time September 07, 2023
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As we wind down the summer months, ITN takes a look at the Top 10 most-read pieces of content from www.itnonline.com ...

Time August 31, 2023
arrow
News | Radiation Therapy

August 30, 2023 — A published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children ...

Time August 30, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 28, 2023 — TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK CEN and IBA, announced that ...

Time August 28, 2023
arrow
Feature | Radiology Education | By Melinda Taschetta-Millane

ITN’s award-winning editorial team delivers industry trends and technology information to the professionals who make ...

Time August 28, 2023
arrow
Subscribe Now